| EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update | Annals of the Rheumatic Diseases | 2017 | 1.6K |
| Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders | Journal of Crohn's and Colitis | 2017 | 837 |
| 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis | Annals of the Rheumatic Diseases | 2017 | 801 |
| Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution | Nature | 2017 | 796 |
| EV-TRACK: transparent reporting and centralizing knowledge in extracellular vesicle research | Nature Methods | 2017 | 560 |
| Intertumoral Heterogeneity within Medulloblastoma Subgroups | Cancer Cell | 2017 | 511 |
| Methodological Guidelines to Study Extracellular Vesicles | Circulation Research | 2017 | 490 |
| Obstacles and opportunities in the functional analysis of extracellular vesicle RNA - an ISEV position paper | Journal of Extracellular Vesicles | 2017 | 410 |
| 3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 2: Surgical Management and Special Situations | Journal of Crohn's and Colitis | 2017 | 387 |
| A European Respiratory Society technical standard: exhaled biomarkers in lung disease | European Respiratory Journal | 2017 | 295 |
| Molecular Structure of the Human CFTR Ion Channel | Cell | 2017 | 285 |
| Guided de-escalation of antiplatelet treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention (TROPICAL-ACS): a randomised, open-label, multicentre trial | Lancet, The | 2017 | 279 |
| The Putative Drp1 Inhibitor mdivi-1 Is a Reversible Mitochondrial Complex I Inhibitor that Modulates Reactive Oxygen Species | Developmental Cell | 2017 | 259 |
| Age-associated physiological and pathological changes at the blood-brain barrier: A review | Journal of Cerebral Blood Flow and Metabolism | 2017 | 236 |
| Molecular interrogation of hypothalamic organization reveals distinct dopamine neuronal subtypes | Nature Neuroscience | 2017 | 226 |
| International Expert Consensus on Switching Platelet P2Y Receptor-Inhibiting Therapies | Circulation | 2017 | 215 |
| Novel targets and future strategies for acute cardioprotection: Position Paper of the European Society of Cardiology Working Group on Cellular Biology of the Heart | Cardiovascular Research | 2017 | 206 |
| Romosozumab (sclerostin monoclonal antibody) versus teriparatide in postmenopausal women with osteoporosis transitioning from oral bisphosphonate therapy: a randomised, open-label, phase 3 trial | Lancet, The | 2017 | 205 |
| Busulfan and melphalan versus carboplatin, etoposide, and melphalan as high-dose chemotherapy for high-risk neuroblastoma (HR-NBL1/SIOPEN): an international, randomised, multi-arm, open-label, phase 3 trial | Lancet Oncology, The | 2017 | 188 |
| European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS) | Redox Biology | 2017 | 185 |
| A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS) | Annals of the Rheumatic Diseases | 2017 | 175 |
| Current and potential imaging applications of ferumoxytol for magnetic resonance imaging | Kidney International | 2017 | 168 |
| Cariprazine versus risperidone monotherapy for treatment of predominant negative symptoms in patients with schizophrenia: a randomised, double-blind, controlled trial | Lancet, The | 2017 | 164 |
| U-BIOPRED clinical adult asthma clusters linked to a subset of sputum omics | Journal of Allergy and Clinical Immunology | 2017 | 163 |
| Digital health is a cultural transformation of traditional healthcare | MHealth | 2017 | 156 |
